← Open Payments lookup

EMILY FUNG: Open Payments

NPI 1720051329 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$186 in 7 payments from 4 companies in 2025. Trend: 2023 $109 · 2024 $91 · 2025 $186

Food & beverage: $186
CompanyPaymentsAmount
Lilly USA, LLC3$75
GlaxoSmithKline, LLC.2$59
Merck Sharp & Dohme LLC1$27
BioMarin Pharmaceutical Inc.1$26

Products named: MOUNJARO, BEXSERO, GARDASIL 9, TRELEGY ELLIPTA, VOXZOGO 1.2mg, JARDIANCE.

Industry payments across CA — which companies pay providers there.